{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:03:36Z","timestamp":1774875816700,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.anai.2012.02.018","type":"journal-article","created":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T03:02:08Z","timestamp":1332298928000},"page":"337-341.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The role of autoimmune testing in chronic idiopathic urticaria"],"prefix":"10.1016","volume":"108","author":[{"given":"Ravi K.","family":"Viswanathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Biagtan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer K.","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2012.02.018_bib1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1081-1206(10)60266-9","article-title":"A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria","volume":"103","author":"Najib","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2012.02.018_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2133.1997.d01-1168.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O'Donnell","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anai.2012.02.018_bib4","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","article-title":"EAACI\/GA2LEN\/EDF\/WAO guideline: management of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2012.02.018_bib5","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-4632.2006.02655.x","article-title":"Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and\/or corticosteroids","volume":"45","author":"Shahar","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.anai.2012.02.018_bib6","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1398-9995.2010.02419.x","article-title":"Cyclosporine-A in severe chronic urticaria: the option for long-term therapy","volume":"65","author":"Kessel","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2012.02.018_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaad.2004.09.023","article-title":"Tacrolimus in the treatment of severe chronic idiopathic urticaria: An open-label prospective study","volume":"52","author":"Kessel","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2012.02.018_bib8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2010.05.047","article-title":"Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab","volume":"126","author":"Magerl","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","article-title":"Treatment of chronic autoimmune urticaria with omalizumab","volume":"122","author":"Kaplan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1067\/mai.2002.126782","article-title":"Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity","volume":"110","author":"Sabroe","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib11","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2011.01.045","article-title":"Clinical utility of the Chronic Urticaria Index","volume":"127","author":"Biagtan","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaci.2004.02.049","article-title":"Chronic urticaria: pathogenesis and treatment","volume":"114","author":"Kaplan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1157\/13101339","article-title":"Chronic urticaria: what is new, where are we headed","volume":"35","author":"Ferrer","year":"2007","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.anai.2012.02.018_bib14","first-page":"402","article-title":"Association between chronic urticaria and thyroid autoimmunity","volume":"16","author":"Cebeci","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.anai.2012.02.018_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000076480","article-title":"Association between chronic urticaria and thyroid autoimmunity: A prospective study involving 99 patients","volume":"208","author":"Verneuil","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.anai.2012.02.018_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/01.all.0000182546.83465.5a","article-title":"The thyroid and urticaria","volume":"5","author":"Dreskin","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1385\/CRIAI:30:1:031","article-title":"Chronic urticaria and thyroid auto-immunity","volume":"30","author":"Doutre","year":"2006","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2500\/aap.2009.30.3185","article-title":"Comparison of the in vivo autologous skin test with in vitro diagnostic tests for diagnosis of chronic autoimmune urticaria","volume":"30","author":"Altrich","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2012.02.018_bib19","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaci.2006.02.016","article-title":"Chronic urticaria sera increase basophil CD203c expression","volume":"117","author":"Yasnowsky","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2009.11.047","article-title":"The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria","volume":"125","author":"Staevska","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1398-9995.2008.01726.x","article-title":"How to assess disease activity in patients with chronic urticaria?","volume":"63","author":"Mlynek","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2012.02.018_bib22","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0091-6749(98)70176-9","article-title":"Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RI(alpha) (alpha-subunit) in chronic urticaria","volume":"101","author":"Ferrer","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib23","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/jid.2008.416","article-title":"Independent evaluation of a commercial test for \u201cautoimmune'' urticaria in normal and chronic urticaria subjects","volume":"129","author":"Eckman","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.anai.2012.02.018_bib24","first-page":"1121","article-title":"Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma","volume":"83","author":"Spencer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anai.2012.02.018_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0019-5154.60348","article-title":"Etiological approach to chronic urticaria","volume":"55","author":"Krupa Shankar","year":"2010","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.anai.2012.02.018_bib26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anai.2012.02.018_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1590\/S0041-87812003000600005","article-title":"Prevalence of antinuclear autoantibodies in the serum of normal blood dornors","volume":"58","author":"Fernandez","year":"2003","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"10.1016\/j.anai.2012.02.018_bib28","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jaad.2010.11.030","article-title":"Clinical utility of testing for autoimmunity in chronic idiopathic urticaria","volume":"66","author":"Lapolla","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anai.2012.02.018_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.anai.2011.06.008","article-title":"Utility of routine laboratory testing in management of chronic urticaria\/angioedema","volume":"107","author":"Tarbox","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2011.06.010","article-title":"A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H(1)-antihistamine-refractory chronic idiopathic urticaria","volume":"128","author":"Saini","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2012.02.018_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archdermatol.2007.5","article-title":"Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients","volume":"144","author":"Delong","year":"2008","journal-title":"Arch Dermatol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120612001421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120612001421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:05:51Z","timestamp":1761051951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120612001421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1081120612001421"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2012.02.018","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of autoimmune testing in chronic idiopathic urticaria","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2012.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}